BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18456705)

  • 1. Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.
    Paramasivam M; Cogoi S; Filichev VV; Bomholt N; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2008 Jun; 36(10):3494-507. PubMed ID: 18456705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
    Rogers FA; Lloyd JA; Tiwari MK
    Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
    Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
    Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding intercalative modulation of G-rich sequence folding: solution structure of a TINA-conjugated antiparallel DNA triplex.
    Garavís M; Edwards PJB; Serrano-Chacón I; Doluca O; Filichev VV; González C
    Nucleic Acids Res; 2024 Mar; 52(5):2686-2697. PubMed ID: 38281138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
    Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
    Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
    Cogoi S; Rapozzi V; Quadrifoglio F; Xodo L
    Biochemistry; 2001 Feb; 40(5):1135-43. PubMed ID: 11170438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines.
    Xodo LE; Manzini G; Quadrifoglio F
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
    Cogoi S; Quadrifoglio F; Xodo LE
    Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
    Mayfield C; Squibb M; Miller D
    Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.
    Cogoi S; Zorzet S; Rapozzi V; Géci I; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2013 Apr; 41(7):4049-64. PubMed ID: 23471001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High physiological thermal triplex stability optimization of twisted intercalating nucleic acids (TINA).
    Bomholt N; Osman AM; Pedersen EB
    Org Biomol Chem; 2008 Oct; 6(20):3714-22. PubMed ID: 18843401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides.
    Xodo LE; Rathinavelan T; Quadrifoglio F; Manzini G; Yathindra N
    Eur J Biochem; 2001 Feb; 268(3):656-64. PubMed ID: 11168404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triplex-forming twisted intercalating nucleic acids (TINAs): design rules, stabilization of antiparallel DNA triplexes and inhibition of G-quartet-dependent self-association.
    Doluca O; Boutorine AS; Filichev VV
    Chembiochem; 2011 Oct; 12(15):2365-74. PubMed ID: 23106083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
    McGuffie EM; Catapano CV
    Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription.
    Liu J; Xu R; Jin Y; Wang D
    Nucleic Acids Res; 2001 Feb; 29(3):783-91. PubMed ID: 11160902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triplex-induced recombination and repair in the pyrimidine motif.
    Kalish JM; Seidman MM; Weeks DL; Glazer PM
    Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions.
    Floris R; Scaggiante B; Manzini G; Quadrifoglio F; Xodo LE
    Eur J Biochem; 1999 Mar; 260(3):801-9. PubMed ID: 10103010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the formation and intracellular stability of purine.(purine/pyrimidine) triplexes.
    Debin A; Malvy C; Svinarchuk F
    Nucleic Acids Res; 1997 May; 25(10):1965-74. PubMed ID: 9115364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
    Kim HG; Miller DM
    Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
    Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
    Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.